Regulatory Affairs Syndicator

Regulatory Affairs Updates and Bulletins by Joe Schwoebel

  • Blog
  • Warning Letters
  • FDA Links
  • Resource
  • Register


« Distinguished Radiologist To Speak about Neurobiological Correlates of Acupuncture at NCCAM’s Distinguished Lecture Series
FDA Cautions Consumers Against Filling U.S. Prescriptions Abroad »

Barr Pharmaceuticals spent $1.7M lobbying in 1Q - Forbes

Published by Google Inc. December 31st, 1969 in Google FDA News, Regulatory Affairs

Barr Pharmaceuticals spent $1.7M lobbying in 1Q
Forbes, NY - 8 hours ago
Generic drug companies market cheaper versions of simpler, chemical drugs, but the Food and Drug Administration does not have the authority to approve …
Pharmacy benefit group spent $158K lobbying in 1Q Forbes
all 9 news articles


Search



Regulatory Affairs Syndicator is powered by WordPress 2.0.3 and K2 Beta Two r167 by Michael and Chris
RSS Entries and RSS Comments